MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Business/Financial News / IBM Watson inks deal with 21 Chinese hospitals

IBM Watson inks deal with 21 Chinese hospitals

August 11, 2016 By Fink Densford Leave a Comment

IBM WatsonIBM‘s (NYSE:IBM) Watson health group said today that inked a deal to supply 21 hospitals in China with its Watson for Oncology platform designed to assist in providing personalized, evidence-based cancer treatment options.

The company said it is partnering with Hangzhou CognitiveCare to introduce more hospitals across China, and touted the partnership as Watson Health’s 1st in China.

“Hangzhou CognitiveCare is eager to bring IBM’s Watson for Oncology to reach every oncologist in China we possibly can. Watson has the power to transform how doctors battle cancer in China and around the world, providing physicians with insights regarding treatment options that help them customize therapeutic recommendations specific to each individual, based on a patient’s specific needs,” Hangzhou CognitiveCare CEO Zhen Tu said in a press release.

Cognitive computing company Hangzhou CognitiveCare will provide sales, service and customer support for doctors in China, including localization. The platform will be available initially in English, with CognitiveCare providing translations for drug labels and treatment guidelines, and will localize dosing based on Chinese medical guidelines, the company said.

“IBM is committed to working with CognitiveCare as the first mover in China to bring Watson Health technologies into this market. Health leaders in Asia-Pacific are leading the way globally in advancing cancer care. The 21 hospitals in China that will adopt the Watson for Oncology offering join world-class facilities that are offering the power of Watson to their physicians and the adoption of Watson in China is indicative of the momentum we are seeing among health professionals worldwide for IBM’s unique cognitive computing platform,” IBM Watson GM Deborah DiSanzo said in a prepared statement.

“Healthcare in China is transforming at a rapid pace but the world’s most populous country faces numerous challenges as it struggles to cope with a precipitous rise in cancer and other diseases. Optimum care for cancer patients often requires a customized, evidence-based approach to treatment due to the unique characteristics of the disease. Watson for Oncology offers great potential to help enable the best possible patient outcomes and is ideally suited to help advance China’s efforts to improve the quality and efficiency of cancer treatment,” Frost & Sullivan Nancy Fabozzi said in prepared remarks.

In June, Watson said its platform will be put to use to help match cancer patients with clinical trials.

The Armonk, N.Y.-based technology giant said Froedtert & the Medical College of Wisconsin Network will adopt the Watson technology for this purpose in a project set to begin this fall. Froedtert/MCW Cancer Network are among the 1st cancer programs nationally to use the technology, according to IBM.

Doctors typically try to match patients to genetically ideal clinical trials that are also the most relevant in the development spectrum. This can be a long process on multiple levels, involving reviews by clinical coordinators who manually sort through patient records and conditions. Watson could hasten the process by analyzing a greater amount of information in less time, including patients’ unique genetic details.

Filed Under: Business/Financial News, Health Information Technology, Oncology, Software / IT Tagged With: IBM

In case you missed it

  • Medtronic faces patent lawsuit over CoreValve tech
  • Orpyx launches sensory insoles with patient monitoring
  • Ortho devicemakers Hensler and Tobra face off in patent lawsuit
  • House bill asks CMS to cover breakthrough devices for Medicare patients
  • Empirical Spine completes enrollment in LimiFlex pivotal trial
  • MolecuLight wins FDA clearance for handheld imaging device
  • Medical device tax will cost 20,000 jobs, report says
  • W.L. Gore officials think they can spur insulin delivery system innovation
  • EPA moves closer to stricter regulations on medtech ethylene oxide sterilization
  • 3DBio Therapeutics wins FDA rare pediatric disease designation for outer ear reconstruction
  • CryoLife wins CE Mark for E-nya thoracic stent graft
  • Edwards projects $5 billion in sales for 2020
  • SPR Therapeutics announces 1000th placement of nerve stimulation device
  • The best places to work for medtech sales reps
  • DePuy Synthes issues urgent field safety notice for USS II Polyaxial 3D heads
  • Haemonetics (HAE) launches SafeTrace Tx in North America
  • Vicarious Surgical wins FDA breakthrough designation for surgical robot

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS